CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
https://www.zacks.com/stock/news/2243068/cvs-health-cvs-exceeds-market-returns-some-facts-to-consider?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2243068
Mar 19, 2024 - In the most recent trading session, CVS Health (CVS) closed at $78.06, indicating a +0.63% shift from the previous trading day.
0
CVS Health (CVS) Ascends But Remains Behind Market: Some Facts to Note
https://www.zacks.com/stock/news/2246961/cvs-health-cvs-ascends-but-remains-behind-market-some-facts-to-note?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246961
Mar 27, 2024 - CVS Health (CVS) concluded the recent trading session at $79.43, signifying a +0.14% move from its prior day's close.
0
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2248599/will-cvs-health-cvs-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2248599
Apr 01, 2024 - CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar
https://www.zacks.com/stock/news/2248935/these-2-retail-and-wholesale-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2248935
Apr 02, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
0
Why Shares of UnitedHealth Group, CVS Health, and Humana Fell Today
https://www.fool.com/investing/2024/04/02/why-shares-of-unitedhealth-group-cvs-health-and-hu/?source=iedfolrf0000001
Apr 02, 2024 - The federal agency that administers the Medicare program just approved a 3.7% payment rate increase. Here's why that's bad for insurance stocks.
0
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
https://www.zacks.com/stock/news/2251113/cvs-health-cvs-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2251113
Apr 05, 2024 - Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Fastenal (FAST) to Post Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2252013/fastenal-fast-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2252013
Apr 08, 2024 - Fastenal's (FAST) Q1 results are likely to reflect manufacturing growth, albeit at a slow pace, with a strong digital strategy and a balanced onsite/offsite mix. Yet, slowing industrial markets are a concern.
0
Many CVS drug plans will cover over-the-counter birth control pill at no cost
https://www.cnbc.com/2024/04/04/cvs-drug-plans-will-cover-otc-birth-control-pill-opill.html
Apr 04, 2024 - The decision by CVS could open the door for more people to prevent unintended pregnancies without a prescription.
0
CVS favors Humira copycats hurting AbbVie’s market share: Evercore
https://seekingalpha.com/news/4090466-cvs-favors-humira-copycats-hurting-abbvies-market?source=feed_sector_healthcare
Apr 17, 2024 - CVS Health's (CVS)decision to drop coverage for Humira and favor its cheaper biosimilars is hurting AbbVie's (ABBV) market dominance. Read more here.
0
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
https://www.zacks.com/stock/news/2258769/cvs-health-cvs-ascends-while-market-falls-some-facts-to-note?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2258769
Apr 19, 2024 - In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.
0